English (United States)
 

Accelerating Clinical Trials in the EU

21/10/22
reduce font Size enlarge font Size print content
 
NWI7357JD58AQ437.jpg

 

Accelerating Clinical Trials in the EU: publication of 2022-2026 workplan 

The European Medicines Agency, European Commission and Heads of Medicines Agencies have published the 2022-2026 workplan of the initiative Accelerating Clinical Trials in the EU (ACT EU). The plan seeks to transform how clinical trials are initiated, designed and run in Europe. Find out more here.

Who should register?

Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.

Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.